These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36549590)

  • 1. Native Size-Exclusion Chromatography-Based Mass Spectrometry Reveals New Components of the Early Heat Shock Protein 90 Inhibition Response Among Limited Global Changes.
    Samant RS; Batista S; Larance M; Ozer B; Milton CI; Bludau I; Wu E; Biggins L; Andrews S; Hervieu A; Johnston HE; Al-Lazikhani B; Lamond AI; Clarke PA; Workman P
    Mol Cell Proteomics; 2023 Feb; 22(2):100485. PubMed ID: 36549590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Proteomics Reveals that Hsp90 Inhibition Dynamically Regulates Global Protein Synthesis in Leishmania mexicana.
    Kalesh K; Sundriyal S; Perera H; Cobb SL; Denny PW
    mSystems; 2021 May; 6(3):. PubMed ID: 33975965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells.
    Samant RS; Clarke PA; Workman P
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6834-9. PubMed ID: 24760825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding proteome of the molecular chaperone HSP90.
    Samant RS; Clarke PA; Workman P
    Cell Cycle; 2012 Apr; 11(7):1301-8. PubMed ID: 22421145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Cellular Response to the HSP90 Inhibition in Human Cells Through Thermal Proteome Profiling.
    Yin K; Wu R
    Mol Cell Proteomics; 2023 Jun; 22(6):100560. PubMed ID: 37119972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy.
    Fierro-Monti I; Echeverria P; Racle J; Hernandez C; Picard D; Quadroni M
    PLoS One; 2013; 8(11):e80425. PubMed ID: 24312219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global proteomic analyses define an environmentally contingent Hsp90 interactome and reveal chaperone-dependent regulation of stress granule proteins and the R2TP complex in a fungal pathogen.
    O'Meara TR; O'Meara MJ; Polvi EJ; Pourhaghighi MR; Liston SD; Lin ZY; Veri AO; Emili A; Gingras AC; Cowen LE
    PLoS Biol; 2019 Jul; 17(7):e3000358. PubMed ID: 31283755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomics of the yeast Hsp70/Hsp90 interactomes during DNA damage reveal chaperone-dependent regulation of ribonucleotide reductase.
    Truman AW; Kristjansdottir K; Wolfgeher D; Ricco N; Mayampurath A; Volchenboum SL; Clotet J; Kron SJ
    J Proteomics; 2015 Jan; 112():285-300. PubMed ID: 25452130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer.
    Mouradian M; Ma IV; Vicente ED; Kikawa KD; Pardini RS
    Nutr Cancer; 2017 Jan; 69(1):92-104. PubMed ID: 27880046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing Order Through Disorder by the Hsp90 Molecular Chaperone.
    Babu N; Freeman BC
    J Mol Biol; 2024 Jul; 436(14):168460. PubMed ID: 38301804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90 inhibition induces both protein-specific and global changes in the ubiquitinome.
    Quadroni M; Potts A; Waridel P
    J Proteomics; 2015 Apr; 120():215-29. PubMed ID: 25782750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between the Hsp90 Chaperone and the HslVU Protease To Regulate the Level of an Essential Protein in Shewanella oneidensis.
    Honoré FA; Maillot NJ; Méjean V; Genest O
    mBio; 2019 May; 10(3):. PubMed ID: 31088919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response.
    Sharma K; Vabulas RM; Macek B; Pinkert S; Cox J; Mann M; Hartl FU
    Mol Cell Proteomics; 2012 Mar; 11(3):M111.014654. PubMed ID: 22167270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Conformational Dynamics of Hsp90 and Its Interactors.
    Chavez JD; Schweppe DK; Eng JK; Bruce JE
    Cell Chem Biol; 2016 Jun; 23(6):716-26. PubMed ID: 27341434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
    Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
    Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery.
    Li T; Jiang HL; Tong YG; Lu JJ
    J Hematol Oncol; 2018 Apr; 11(1):59. PubMed ID: 29699578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models.
    Jensen MR; Schoepfer J; Radimerski T; Massey A; Guy CT; Brueggen J; Quadt C; Buckler A; Cozens R; Drysdale MJ; Garcia-Echeverria C; Chène P
    Breast Cancer Res; 2008; 10(2):R33. PubMed ID: 18430202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells.
    Eskew JD; Sadikot T; Morales P; Duren A; Dunwiddie I; Swink M; Zhang X; Hembruff S; Donnelly A; Rajewski RA; Blagg BS; Manjarrez JR; Matts RL; Holzbeierlein JM; Vielhauer GA
    BMC Cancer; 2011 Oct; 11():468. PubMed ID: 22039910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
    Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein.
    Gano JJ; Simon JA
    Mol Cell Proteomics; 2010 Feb; 9(2):255-70. PubMed ID: 19875381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.